pharmaceutical investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring